References
[1] Haissaguerre M, Gencel L, Fischer B, Le Metayer P, Poquet F, Marcus FI, Clementy J: Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994; 5:1045-1052.
[2] Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659-666.
[3] Piccini JP, Daubert JP: Cryoablation of atrial fibrillation. J Interv Card Electrophysiol 2011; 32:233-242.
[4] Dukkipati SR, Neuzil P, Kautzner J, Petru J, Wichterle D, Skoda J, Cihak R, Peichl P, Dello Russo A, Pelargonio G, Tondo C, Natale A, Reddy VY: The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies. Heart Rhythm 2012; 9:919-925.
[5] Ullah W, McLean A, Tayebjee MH, Gupta D, Ginks MR, Haywood GA, O’Neill M, Lambiase PD, Earley MJ, Schilling RJ, Group** UKMT: Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data. Heart Rhythm 2016; 13:1761-1767.
[6] Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH: EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 2015; 17:1229-1235.
[7] Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot N, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2017; 14:e275-e444.
[8] Andrade JG, Monir G, Pollak SJ, Khairy P, Dubuc M, Roy D, Talajic M, Deyell M, Rivard L, Thibault B, Guerra PG, Nattel S, Macle L: Pulmonary vein isolation using ”contact force” ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation–a prospective study. Heart Rhythm 2014; 11:1919-1924.
[9] Anter E, Contreras-Valdes FM, Shvilkin A, Tschabrunn CM, Josephson ME: Acute pulmonary vein reconnection is a predictor of atrial fibrillation recurrence following pulmonary vein isolation. J Interv Card Electrophysiol 2014; 39:225-232.
[10] Anter E, Tschabrunn CM, Contreras-Valdes FM, Buxton AE, Josephson ME: Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation. Heart Rhythm 2014; 11:783-790.
[11] Haines DE: Cooking With Radiofrequency Energy: What Is the Right Recipe? JACC Clin Electrophysiol 2018; 4:480-482.
[12] Nakagawa H, Wittkampf FH, Yamanashi WS, Pitha JV, Imai S, Campbell B, Arruda M, Lazzara R, Jackman WM: Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation 1998; 98:458-465.
[13] Bruce GK, Bunch TJ, Milton MA, Sarabanda A, Johnson SB, Packer DL: Discrepancies between catheter tip and tissue temperature in cooled-tip ablation: relevance to guiding left atrial ablation. Circulation 2005; 112:954-960.
[14] Guy DJ, Boyd A, Thomas SP, Ross DL: Increasing power versus duration for radiofrequency ablation with a high superfusate flow: implications for pulmonary vein ablation? Pacing Clin Electrophysiol 2003; 26:1379-1385.
[15] Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque JP, Kautzner J, Shah D, Michaud G, Wharton M, Harari D, Mahapatra S, Lambert H, Mansour M: Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study. Circulation 2015; 132:907-915.
[16] Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, ThermoCool AFTI: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303:333-340.
[17] Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B, Stagg RB, Boo LM, Marchlinski FE: Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol 2014; 64:647-656.
[18] Itoh T, Kimura M, Tomita H, Sasaki S, Owada S, Horiuchi D, Sasaki K, Ishida Y, Kinjo T, Okumura K: Reduced residual conduction gaps and favourable outcome in contact force-guided circumferential pulmonary vein isolation. Europace 2016; 18:531-537.
[19] Reddy VY, Pollak S, Lindsay BD, McElderry HT, Natale A, Kantipudi C, Mansour M, Melby DP, Lakkireddy D, Levy T, Izraeli D, Sangli C, Wilber D: Relationship Between Catheter Stability and 12-Month Success After Pulmonary Vein Isolation: A Subanalysis of the SMART-AF Trial. JACC Clin Electrophysiol 2016; 2:691-699.
[20] Chinitz LA, Melby DP, Marchlinski FE, Delaughter C, Fishel RS, Monir G, Patel AM, Gibson DN, Athill CA, Ming Boo L, Stagg R, Natale A: Safety and efficiency of porous-tip contact-force catheter for drug-refractory symptomatic paroxysmal atrial fibrillation ablation: results from the SMART SF trial. Europace 2018; 20:f392-f400.
[21] Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govari A, Anter E: High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization. JACC Clin Electrophysiol 2018; 4:467-479.
[22] Yuyun MF, Stafford PJ, Sandilands AJ, Samani NJ, Andre Ng G: The impact of power output during percutaneous catheter radiofrequency ablation for atrial fibrillation on efficacy and safety outcomes: a systematic review. J Cardiovasc Electrophysiol 2013; 24:1216-1223.
[23] Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A, Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Purerfellner H: Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol 2019; 5:778-786.
[24] Haines DE: The biophysics of radiofrequency catheter ablation in the heart: the importance of temperature monitoring. Pacing Clin Electrophysiol 1993; 16:586-591.
[25] Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa M, Kitamura T, Frontera A, Cheniti G, Pambrun T, Klotz N, Denis A, Derval N, Cochet H, Sacher F, Hocini M, Haissaguerre M, Jais P: High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics. J Cardiovasc Electrophysiol 2018; 29:1570-1575.
[26] Bhaskaran A, Chik W, Pouliopoulos J, Nalliah C, Qian P, Barry T, Nadri F, Samanta R, Tran Y, Thomas S, Kovoor P, Thiagalingam A: Five seconds of 50-60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation. Europace 2017; 19:874-880.
[27] Borne RT, Sauer WH, Zipse MM, Zheng L, Tzou W, Nguyen DT: Longer Duration Versus Increasing Power During Radiofrequency Ablation Yields Different Ablation Lesion Characteristics. JACC Clin Electrophysiol 2018; 4:902-908.
[28] Ali-Ahmed F, Goyal V, Patel M, Orelaru F, Haines DE, Wong WS: High-power, low-flow, short-ablation duration-the key to avoid collateral injury? J Interv Card Electrophysiol 2019; 55:9-16.
[29] Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler V, Telishevska M, Otgonbayar U, Koch-Buttner K, Lennerz C, Bartkowiak M, Kornmayer M, Rousseva E, Brkic A, Grebmer C, Kolb C, Hessling G, Deisenhofer I: Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Europace 2020; 22:388-393.
[30] Vassallo F, Cunha C, Serpa E, Meigre LL, Carloni H, Simoes A, Jr., Hespanhol D, Lovatto CV, Batista W, Jr., Serpa R: Comparison of high-power short-duration (HPSD) ablation of atrial fibrillation using a contact force-sensing catheter and conventional technique: Initial results. J Cardiovasc Electrophysiol 2019; 30:1877-1883.
[31] Winkle RA, Mohanty S, Patrawala RA, Mead RH, Kong MH, Engel G, Salcedo J, Trivedi CG, Gianni C, Jais P, Natale A, Day JD: Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations. Heart Rhythm 2019; 16:165-169.
[32] Baher A, Kheirkhahan M, Rechenmacher SJ, Marashly Q, Kholmovski EG, Siebermair J, Acharya M, Aljuaid M, Morris AK, Kaur G, Han FT, Wilson BD, Steinberg BA, Marrouche NF, Chelu MG: High-Power Radiofrequency Catheter Ablation of Atrial Fibrillation: Using Late Gadolinium Enhancement Magnetic Resonance Imaging as a Novel Index of Esophageal Injury. JACC Clin Electrophysiol 2018; 4:1583-1594.
[33] Matiello M, Mont L, Tamborero D, Berruezo A, Benito B, Gonzalez E, Brugada J: Cooled-tip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: comparison of efficacy, safety, and lesion extension. Europace 2008; 10:955-960.
[34] Kanj MH, Wazni O, Fahmy T, Thal S, Patel D, Elayi C, Di Biase L, Arruda M, Saliba W, Schweikert RA, Cummings JE, Burkhardt JD, Martin DO, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Potenza D, Fanelli R, Massaro R, Forleo G, Natale A: Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. J Am Coll Cardiol 2007; 49:1634-1641.
[35] Nilsson B, Chen X, Pehrson S, Svendsen JH: The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation. Europace 2006; 8:962-965.
[36] Yamada T, Murakami Y, Okada T, Okamoto M, Shimizu T, Toyama J, Yoshida Y, Tsuboi N, Ito T, Muto M, Kondo T, Inden Y, Hirai M, Murohara T: Can segmental pulmonary vein ablation reduce the recurrence of atrial fibrillation when using a higher RF power, larger tip electrode catheter, and additional RF deliveries?: the limitations of point-by-point RF ablation. Int Heart J 2006; 47:219-228.
[37] Mansour M, Ruskin J, Keane D: Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15:532-537.
[38] Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clementy J: Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101:1409-1417.
[39] Yavin HD, Leshem E, Shapira-Daniels A, Sroubek J, Barkagan M, Haffajee CI, Cooper JM, Anter E: Impact of High-Power Short-Duration Radiofrequency Ablation on Long-Term Lesion Durability for Atrial Fibrillation Ablation. JACC: Clinical Electrophysiology 2020:1154.
[40] Winkle RA, Moskovitz R, Hardwin Mead R, Engel G, Kong MH, Fleming W, Salcedo J, Patrawala RA, Tranter JH, Shai I: Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheters. J Interv Card Electrophysiol 2018; 52:1-8.
[41] Winkle RA, Mead RH, Engel G, Patrawala RA: Atrial fibrillation ablation: ”perpetual motion” of open irrigated tip catheters at 50 W is safe and improves outcomes. Pacing Clin Electrophysiol 2011; 34:531-539.
[42] Dixit S, Gerstenfeld EP, Callans DJ, Cooper JM, Lin D, Russo AM, Verdino RJ, Patel VV, Kimmel SE, Ratcliffe SJ, Hsia HH, Nayak HM, Zado E, Ren JF, Marchlinski FE: Comparison of cool tip versus 8-mm tip catheter in achieving electrical isolation of pulmonary veins for long-term control of atrial fibrillation: a prospective randomized pilot study. J Cardiovasc Electrophysiol 2006; 17:1074-1079.
[43] Castrejon-Castrejon S, Martinez Cossiani M, Ortega Molina M, Escobar C, Froilan Torres C, Gonzalo Bada N, Diaz de la Torre M, Suarez Parga JM, Lopez Sendon JL, Merino JL: Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study. J Interv Card Electrophysiol 2020; 57:57-65.
[44] Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J: Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol 2013; 62:531-539.
[45] Hwang ES, Pak HN, Park SW, Park JS, Joung B, Choi D, Lee MH, Kim YH: Risks and benefits of an open irrigation tip catheter in intensive radiofrequency catheter ablation in patients with non-paroxysmal atrial fibrillation. Circ J 2010; 74:644-649.
[46] Bunch TJ, Day JD: Novel ablative approach for atrial fibrillation to decrease risk of esophageal injury. Heart Rhythm 2008; 5:624-627.
[47] Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ, Waktare JEP, Todd DM, Hall MCS, Snowdon RL, Modi S, Gupta D: Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace 2017; 19:775-783.
[48] Armstrong RB: Magnitude and distribution of muscle blood flow in conscious animals during locomotory exercise. Med Sci Sports Exerc 1988; 20:S119-123.
[49] Hsu LF, Jais P, Hocini M, Sanders P, Scavee C, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Clementy J, Haissaguerre M: Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol 2005; 28 Suppl 1:S106-109.
[50] Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, Saad E, Bash D, Yamada H, Jaber W, Schweikert R, Tchou P, Abdul-Karim A, Saliba W, Natale A: Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 107:2710-2716.
[51] Iwasawa J, Koruth JS, Petru J, Dujka L, Kralovec S, Mzourkova K, Dukkipati SR, Neuzil P, Reddy VY: Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation. J Am Coll Cardiol 2017; 70:542-553.